Adaptive Biotechnologies (ADPT) Short-term Investments (2018 - 2026)

Adaptive Biotechnologies has reported Short-term Investments for 9 years, with the latest figure at $140.8 million in Q1 2026.

• Quarterly Short-term Investments fell 1.42% year-over-year to $140.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $140.8 million (down 1.42% YoY) and the FY2025 annual result came in at $156.5 million, down 10.26% from the prior year.
• Short-term Investments eased to $140.8 million in Q1 2026 per ADPT's latest filing, from $156.5 million in the prior quarter.
• Over five years, Short-term Investments peaked at $408.2 million in Q4 2022 and troughed at $140.8 million in Q1 2026.
• A 5-year average of $239.7 million and a median of $237.6 million in 2024 frame the typical range for Short-term Investments.
• The widest YoY moves for Short-term Investments: up 90.74% in 2022, down 53.99% in 2022.
• Over 5 years, Short-term Investments stood at $408.2 million in 2022, then tumbled by 31.07% to $281.3 million in 2023, then sank by 38.02% to $174.4 million in 2024, then declined by 10.26% to $156.5 million in 2025, then declined by 10.05% to $140.8 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $140.8 million, $156.5 million, and $157.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.